Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic Implications
<b>Background</b>: Endometrial carcinoma (EC) is the most common gynecological malignancy, with increasing incidence contributing to a significant global health burden. Despite recent advancements, the molecular mechanisms underlying EC progression remain insufficiently understood, limit...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/5/1136 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849711084212060160 |
|---|---|
| author | Hongfei Yu Lingling Zu Yuqin Zang Fei Teng Tao Wang Ming Wu Yingmei Wang Fengxia Xue |
| author_facet | Hongfei Yu Lingling Zu Yuqin Zang Fei Teng Tao Wang Ming Wu Yingmei Wang Fengxia Xue |
| author_sort | Hongfei Yu |
| collection | DOAJ |
| description | <b>Background</b>: Endometrial carcinoma (EC) is the most common gynecological malignancy, with increasing incidence contributing to a significant global health burden. Despite recent advancements, the molecular mechanisms underlying EC progression remain insufficiently understood, limiting the development of targeted therapies. This study aims to investigate the role of <i>nucleoside diphosphate-linked moiety X motif 5 (NUDT5)</i> in EC and evaluate its potential as a biomarker and therapeutic target. <b>Methods</b>: This study analyzed gene expression data from The Cancer Genome Atlas and performed tissue microarray validation to assess <i>NUDT5</i> expression in EC samples. Immunohistochemistry was used to evaluate NUDT5 protein levels and their correlation with clinicopathological features. Functional assays, including cell proliferation, migration, invasion, and apoptosis analysis, were conducted to determine the oncogenic effects of NUDT5 in vitro. Weighted gene co-expression network analysis (WGCNA) and experimental validation were performed to explore the impact of NUDT5 on the PI3K-AKT signaling pathway, while tumor growth assays in xenograft models assessed the therapeutic potential of NUDT5 inhibition in vivo. <b>Results</b>: <i>NUDT5</i> was significantly overexpressed in EC tissues and correlated with advanced histological grade and poor prognosis. Functional experiments demonstrated that NUDT5 promotes cell proliferation, migration, and invasion while inhibiting apoptosis. Mechanistically, NUDT5 activated the PI3K-AKT pathway, contributing to tumor progression. In vivo, <i>NUDT5</i> knockdown suppressed tumor growth. <b>Conclusions</b>: These findings suggest that <i>NUDT5</i> functions as an oncogene in EC, serving as a potential diagnostic and prognostic biomarker. Targeting NUDT5 may provide a novel therapeutic strategy for EC management. |
| format | Article |
| id | doaj-art-cbad2e00586a49d5bd5b4594c2b9a5e4 |
| institution | DOAJ |
| issn | 2227-9059 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj-art-cbad2e00586a49d5bd5b4594c2b9a5e42025-08-20T03:14:42ZengMDPI AGBiomedicines2227-90592025-05-01135113610.3390/biomedicines13051136Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic ImplicationsHongfei Yu0Lingling Zu1Yuqin Zang2Fei Teng3Tao Wang4Ming Wu5Yingmei Wang6Fengxia Xue7Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District, Tianjin 300070, ChinaTianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District, Tianjin 300070, ChinaDepartment of Gynecology and Obstetrics, Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District, Tianjin 300070, ChinaDepartment of Gynecology and Obstetrics, Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District, Tianjin 300070, ChinaDepartment of Gynecology and Obstetrics, Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District, Tianjin 300070, ChinaDepartment of Gynecology and Obstetrics, Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District, Tianjin 300070, ChinaDepartment of Gynecology and Obstetrics, Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District, Tianjin 300070, ChinaDepartment of Gynecology and Obstetrics, Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District, Tianjin 300070, China<b>Background</b>: Endometrial carcinoma (EC) is the most common gynecological malignancy, with increasing incidence contributing to a significant global health burden. Despite recent advancements, the molecular mechanisms underlying EC progression remain insufficiently understood, limiting the development of targeted therapies. This study aims to investigate the role of <i>nucleoside diphosphate-linked moiety X motif 5 (NUDT5)</i> in EC and evaluate its potential as a biomarker and therapeutic target. <b>Methods</b>: This study analyzed gene expression data from The Cancer Genome Atlas and performed tissue microarray validation to assess <i>NUDT5</i> expression in EC samples. Immunohistochemistry was used to evaluate NUDT5 protein levels and their correlation with clinicopathological features. Functional assays, including cell proliferation, migration, invasion, and apoptosis analysis, were conducted to determine the oncogenic effects of NUDT5 in vitro. Weighted gene co-expression network analysis (WGCNA) and experimental validation were performed to explore the impact of NUDT5 on the PI3K-AKT signaling pathway, while tumor growth assays in xenograft models assessed the therapeutic potential of NUDT5 inhibition in vivo. <b>Results</b>: <i>NUDT5</i> was significantly overexpressed in EC tissues and correlated with advanced histological grade and poor prognosis. Functional experiments demonstrated that NUDT5 promotes cell proliferation, migration, and invasion while inhibiting apoptosis. Mechanistically, NUDT5 activated the PI3K-AKT pathway, contributing to tumor progression. In vivo, <i>NUDT5</i> knockdown suppressed tumor growth. <b>Conclusions</b>: These findings suggest that <i>NUDT5</i> functions as an oncogene in EC, serving as a potential diagnostic and prognostic biomarker. Targeting NUDT5 may provide a novel therapeutic strategy for EC management.https://www.mdpi.com/2227-9059/13/5/1136endometrial carcinoma<i>NUDT5</i>prognostic factorPI3K-AKT pathwaytumor progression |
| spellingShingle | Hongfei Yu Lingling Zu Yuqin Zang Fei Teng Tao Wang Ming Wu Yingmei Wang Fengxia Xue Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic Implications Biomedicines endometrial carcinoma <i>NUDT5</i> prognostic factor PI3K-AKT pathway tumor progression |
| title | Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic Implications |
| title_full | Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic Implications |
| title_fullStr | Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic Implications |
| title_full_unstemmed | Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic Implications |
| title_short | Assessment of NUDT5 in Endometrial Carcinoma: Functional Insights, Prognostic and Therapeutic Implications |
| title_sort | assessment of nudt5 in endometrial carcinoma functional insights prognostic and therapeutic implications |
| topic | endometrial carcinoma <i>NUDT5</i> prognostic factor PI3K-AKT pathway tumor progression |
| url | https://www.mdpi.com/2227-9059/13/5/1136 |
| work_keys_str_mv | AT hongfeiyu assessmentofnudt5inendometrialcarcinomafunctionalinsightsprognosticandtherapeuticimplications AT linglingzu assessmentofnudt5inendometrialcarcinomafunctionalinsightsprognosticandtherapeuticimplications AT yuqinzang assessmentofnudt5inendometrialcarcinomafunctionalinsightsprognosticandtherapeuticimplications AT feiteng assessmentofnudt5inendometrialcarcinomafunctionalinsightsprognosticandtherapeuticimplications AT taowang assessmentofnudt5inendometrialcarcinomafunctionalinsightsprognosticandtherapeuticimplications AT mingwu assessmentofnudt5inendometrialcarcinomafunctionalinsightsprognosticandtherapeuticimplications AT yingmeiwang assessmentofnudt5inendometrialcarcinomafunctionalinsightsprognosticandtherapeuticimplications AT fengxiaxue assessmentofnudt5inendometrialcarcinomafunctionalinsightsprognosticandtherapeuticimplications |